UK Health Regulator Approves Moderna Covid-19 Vaccine to 12 and 17-year-old Children


On Tuesday, 17th August 2021, the health regulator of the United Kingdom has now given the approval to the novel corona virus vaccine developed by Moderna to be used in the children aging between 12 years to 17 years of age, and this comes weeks after the corona virus vaccine of Pfizer and BioNTech has got the approval for use in children ahead of re-opening of the schools.

The MHRA (Medicines and Healthcare Products Regulatory Agency) has confirmed that, the covid-19 vaccine called as ‘Spikevax’, is effective and safe in for the children coming under the age group of 12 and 17 years, and most of the children in the country might develop no symptoms or mild symptoms with the novel corona virus, but they are still able to spread the virus to other children and some might remain at the risk of becoming severely ill.

The corona virus vaccine developed by Moderna had been recommended to be used in the adolescents by the regulators of the Europe in July 2021 and the company is still awaiting the authorisation of the United States, and it has already been approved for the adult people in the United Kingdom.

READ  Amazon Launched Digital Healthcare Accelerator Program for Startups in US

United Kingdom’s Joint Committee on Vaccination and Immunisation (JCVI) have given the approval for the 16 and 17-year-old children for getting their first dose of the novel corona virus vaccine produced by Pfizer and BioNTech before the new educational year in September 2021.

The MHRA said, it does not identify any new side effects with the novel corona virus vaccine and the data on the safety of the vaccine had been comparable with the data of the young adults, along with the side effects mostly being mild and moderate, that mainly includes fatigue or sore arms.